IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 11875 
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Effect of pioglitazone on the abrogated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart

Mittal Dhiraj, Taliyan Rajeev, Sharma P L, Yadav Harlokesh Narayan

Year : 2016| Volume: 48| Issue : 1 | Page no: 59-63

   This article has been cited by
1 Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
PÚter Ferdinandy, Ioanna Andreadou, Gary F. Baxter, Hans Erik B°tker, Sean M. Davidson, Dobromir Dobrev, Bernard J. Gersh, Gerd Heusch, Sandrine Lecour, Marisol Ruiz-Meana, Coert J. Zuurbier, Derek J. Hausenloy, Rainer Schulz, Finn Olav Levy
Pharmacological Reviews. 2023; 75(1): 159
[Pubmed]  [Google Scholar] [DOI]
2 Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug
Lorenzo Nesti, Domenico Tric˛, Alessandro Mengozzi, Andrea Natali
Cardiovascular Diabetology. 2021; 20(1)
[Pubmed]  [Google Scholar] [DOI]
3 Pretreatment of ghrelin protects H9c2 cells against hypoxia/reoxygenation-induced cell death via PI3K/AKT and AMPK pathways
Yanbo Chen, Honggang Wang, Yong Zhang, Zhengping Wang, Shanshan Liu, Lianqun Cui
Artificial Cells, Nanomedicine, and Biotechnology. 2019; 47(1): 2179
[Pubmed]  [Google Scholar] [DOI]


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow